An Assessment of Rapid Streptococcal Tests in Community Clinics in Israel

Status Completed

Clinical Trial Summary

There is a large over-use of antibiotics in family medicine, especially in upper respiratory tract infections.

This study is designed to determine if the use of rapid Streptococcal tests in primary care clinics can lower the rate of antibiotic use while not missing bacterial infections.

Clinical Trial Description

Pharyngitis is a clinical diagnosis which requires antibiotic treatment only if caused by group A Streptococcus (GAS).

However, it is impossible to identify by clinical signs alone those patients whose symptoms are caused by this pathogen.

Diagnosis demands a throat culture, which requires at least 24 hours to rule in infection and 48 hours to rule it out.

Rapid Streptococcal tests (RST) based on antigen identification have been in use for over 10 years. These allow determination of the presence of GAS within 10 minutes using tests designed for point of care use.

While the specificity of these tests is generally reported as high (90-95%), the sensitivity is quoted at between 60% and 90% , depending on author affiliation, place of testing and type of test.

Various protocols have been put forward, these combine clinical signs (Centor criteria) with RST or throat cultures in order to lower antibiotic over-use.

These protocols are often under-used by primary physicians, even when RSTs are available.

Clalit health services, the largest HMO in Israel, has decided to evaluate all the RSTs available in the country in community clinic settings in order to determine the feasibility of adopting these tests to improve clinical care.

The sensitivity, specificity and ease-of-use will be assessed in 25 clinics in various settings (urban and rural). Gold standard will be a standard throat culture processed in the district laboratory.

The effect of point-of-care testing will be estimated by requiring physicians to decide on antibiotic use before receiving the result of the RST. (They will be free to change this decision after the test).

Clinics were selected by number of throat cultures sent in previous years. The number of patients was determined using the positivity rates of 2005. The results of this study will enable us to estimate the benefit and cost of adopting RSTs, and to determine in which situations they will be most efficacious. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Pharyngitis
Streptococcus Pyogenes Identification
Streptococcus Pyogenes Infection

Clinical Trial Details

NCT number	NCT00535093
Study type	Interventional
Source	Meir Medical Center
Contact
Status	Completed
Phase	N/A
Start date	October 2007
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01453400` - Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain	Phase 3
Completed	`NCT04016051` - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections	Phase 3
Recruiting	`NCT01681667` - Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain	Phase 4
Completed	`NCT00527852` - Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis	N/A
Completed	`NCT02178293` - Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride	Phase 4
Active, not recruiting	`NCT05127161` - Broad Implementation of Outpatient Stewardship	N/A
Withdrawn	`NCT02535962` - Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)	Phase 2
Not yet recruiting	`NCT02252419` - Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat	N/A
Completed	`NCT00798018` - Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena	N/A
Completed	`NCT00148499` - Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis	Phase 3
Completed	`NCT00095368` - APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat	Phase 3
Recruiting	`NCT06027593` - Using Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship Interventions	N/A
Recruiting	`NCT03720301` - The Use of Osteopathic Medical Manipulation to Decrease the Incidence and Severity of Post-Operative Sore Throat	N/A
Completed	`NCT01361399` - Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold	Phase 3
Completed	`NCT01048866` - A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis	Phase 3
Completed	`NCT01398696` - Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour	Phase 4
Completed	`NCT01049334` - A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis	Phase 3
Completed	`NCT00547391` - Recurrent Throat Infections and Tonsillectomy	Phase 4
Completed	`NCT00242281` - APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat	Phase 3
Completed	`NCT01465009` - Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold	Phase 4